Morphological and Ancillary Features of Uterine Leiomyosarcoma: Case Report

被引:3
作者
Bosoteanu, Madalina [1 ,2 ]
Voda, Raluca Ioana [1 ,3 ]
Aschie, Mariana [1 ,3 ,4 ]
Bosoteanu, Luana-Andreea [5 ,6 ]
Baltatescu, Gabriela Izabela [1 ,3 ]
机构
[1] Sf Apostol Andrei Emergency Cty Hosp, Clin Serv Pathol, Constanta, Romania
[2] Ovidius Univ Constanta, Fac Med, Dept Pathol, Constanta, Romania
[3] Ovidius Univ Constanta, Ctr Res & Dev Morphol & Genet Studies Malignant P, 145 Tomis Ave, Constanta 900470, Romania
[4] Acad Med Sci Romania, Bucharest, Romania
[5] Elias Emergency Univ Hosp, Dermatovenerol Dept, Bucharest, Romania
[6] Ovidius Univ Constanta, Sch Med, Inst Doctoral Studies, Constanta, Romania
来源
CLINICAL PATHOLOGY | 2022年 / 15卷
关键词
Cytology; differentiation; immunohistochemistry; mesenchymal tumor; uterine leiomyosarcoma; EXPRESSION; CANCER; TUMOR; P16; P53;
D O I
10.1177/2632010X221105224
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We report a rare case of giant uterine leiomyosarcoma in a postmenopausal woman, whose diagnosis was initially suspected at the evaluation of the abdominal efusion, and confirmed after the pathological examination of the uterus in association with the ancillary tests. The evaluation of the abdominal fluid showed single or clusters of malignant, round or spindle-shaped cells. On microscopic examination of the surgical specimen, a dense cell proliferation of spindle cells, with moderate to severe nuclear pleomorphism and significant mitotic activity was observed. Immunohistochemical evaluation demonstrated the loss of myocytic differentiation by focal, weakly positive expression of smooth muscle actin and desmin. The data presented in this case emphasize the relevance of the cytological examination, although the latter has only indicative value, especially since it is an aggressive tumor, frequently associated with mutant expression of p53. In our case, the first indication of the presence of uterine sarcoma was given by the presence of atypical cells in the peritoneal fluid.
引用
收藏
页数:3
相关论文
共 22 条
  • [1] Azimpouran Mahzad, 2016, Niger Med J, V57, P54, DOI 10.4103/0300-1652.180567
  • [2] Bosoteanu M, 2019, ROM J MORPHOL EMBRYO, V60, P963
  • [3] Dandapani M., 2015, CASE REP OBSTET GYNE, V2015
  • [4] Progressive loss of myogenic differentiation in leiomyosarcoma has prognostic value
    Demicco, Elizabeth G.
    Boland, Genevieve M.
    Savannah, Kari J. Brewer
    Lusby, Kristelle
    Young, Eric D.
    Ingram, Davis
    Watson, Kelsey L.
    Bailey, Marshall
    Guo, Xiangqian
    Hornick, Jason L.
    van de Rijn, Matt
    Wang, Wei-Lien
    Torres, Keila E.
    Lev, Dina
    Lazar, Alexander J.
    [J]. HISTOPATHOLOGY, 2015, 66 (05) : 627 - 638
  • [5] Liang Y, 2015, INT J CLIN EXP PATHO, V8, P7196
  • [6] Significance of Malignant Peritoneal Cytology on Survival of Women with Uterine Sarcoma
    Matsuo, Koji
    Matsuzaki, Shinya
    Nusbaum, David J.
    Ki, Sohee
    Chang, Erica J.
    Klar, Maximilian
    Roman, Lynda D.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (03) : 1740 - 1748
  • [7] Ki-67 expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignant potential (STUMP) and uterine leiomyosarcomas (LMS)
    Mayerhofer, K
    Lozanov, P
    Bodner, K
    Bodner-Adler, B
    Kimberger, O
    Czerwenka, K
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2004, 83 (11) : 1085 - 1088
  • [8] Ki-67 and vascular endothelial growth factor expression in uterine leiomyosarcoma
    Mayerhofer, K
    Lozanov, P
    Bodner, K
    Bodner-Adler, B
    Obermair, A
    Kimberger, O
    Czerwenka, K
    [J]. GYNECOLOGIC ONCOLOGY, 2004, 92 (01) : 175 - 179
  • [9] Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential
    O'Neill, C. J.
    McBride, H. A.
    Connolly, L. E.
    McCluggage, W. G.
    [J]. HISTOPATHOLOGY, 2007, 50 (07) : 851 - 858
  • [10] The treatment of uterine sarcomas
    Reichardt, P.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 151 - 157